(Total Views: 627)
Posted On: 04/12/2023 10:20:18 PM
Post# of 154433
Re: chazzledazzle #134085
Merck’s recent clinical trials with combo therapies have FAILED in the past couple of weeks. There were at least 2 and maybe 3 drugs they tried in combination with Keytruda, and results were either no different or actually worse.
This cuts both ways. 2 scenarios:
1) Merck is now really desperate to find a combo drug so they can market a new formulation and thus extend some patent protection, so maybe they will want to try it with LeronlimabYamab.
2) There is something about Keytruda that makes other drugs ineffective when combined with Keytruda.
Of course, there is also Scenario 3
3) They don’t give a rip about CYDY and Leronlimab
This cuts both ways. 2 scenarios:
1) Merck is now really desperate to find a combo drug so they can market a new formulation and thus extend some patent protection, so maybe they will want to try it with LeronlimabYamab.
2) There is something about Keytruda that makes other drugs ineffective when combined with Keytruda.
Of course, there is also Scenario 3
3) They don’t give a rip about CYDY and Leronlimab
(3)
(0)
